top of page

Xiaoli Mi  receives the Damon Runyon Physician-Scientist Training Award! 3/20/2024

Landau lab receives award for the NIH Common Fund's Somatic Mutation across Human Tissue (SMaHT) Network with the Satija lab! 5/11/2023

Dan Landau receives an Established Investigator Award from the Melanoma Research Alliance! 5/1/2023

Adam Widman receives a Young Investigator Award from the Melanoma Research Alliance! 5/1/2023

Xiaoli Mi receives the American Society of Hematology Research Training Award for Fellows! 4/21/2023

Congratulations to Landau lab members Dr. Adam Widman and Dr. Franco Izzo, winners of the New York Genome Center's Recognition Awards 2022  12/9/2022

Adam Widman, Innovation and Discovery Award

Franco Izzo, Innovation and Discovery Award


Dr. Franco Izzo

Weill Cornell Medicine Impact Feature covering the lab's work on single-cell mutiomics and cancer evolution 11/14/2022

Screen Shot 2022-11-14 at 11.25.41 AM.png
sontag animation.jpg

Dan Landau participates in a panel about Machine Learning in Oncology at the Cancer Summit 04/24/2022


Dan Landau receives the Mark Foundation Emerging Leader award


Dan Landau receives the Jeanne and Herbert Siegel WCM Faculty Development Award for scientific excellence


C2i Genomics, Landau lab start up is selected as a finalist for the 2021 Nature Spinoff Prize!


Dan Landau receives the Jeanne and Herbert Siegel WCM Faculty Development Award


Neville Dusaj receives the F30 NCI Award!


Our cfDNA work selected as top 10 Clinical Research Achievement by the Clinical Research Forum


Franco Izzo receives the ASH Fellow to Faculty Award!


Dan Landau receives the Sontag Foundation Distinguished Scientist Award


Anna Nam receives the NIH Director's Early Independence Award and starts her own lab!


Landau lab is awarded NHGRI Center of Excellence in Genomic Science award with Satija and Smibert labs at NYGC! 


Dan Landau receives the Vallee Scholar Award


Anna Nam receives the Career Award for Medical Scientists from Burroughs Wellcome Fund! 


Adam Widman receives a Young Investigator Award from ASCO! 


Federico Gaiti receives a K99 award from the NCI! 


Landau lab receives an award from CZI together with a team led by Giannerelli lab (MSSM) to develop single-cell methods to study inflammation 


Dan Landau receives the Leukemia Lymphoma Society Scholar Award 


Federico Gaiti receives the Lymphoma Research Foundation award! 


Dan Landau is selected as a member of the American Society of Clinical Investigation


Anna Nam receives K08 from NHLBI! 


Federico Gaiti selected as Leukemia Lymphoma Society Fellow! 


Anna Nam selected as Leukemia Lymphoma Society Special Fellow! 


Landau lab receives an ASPIRE award from the Mark Foundation to develop liquid biopsy methods for pre-invasive lesions 


Landau lab in collaboration with the Kharas lab (MSKCC) receives funding from Tri-Institutional's Stem Cell Initiative Award to develop novel single-cell methods to study hematopoietic stem cell fate decisions. 


Federico Gaiti receives the American Society of Hematology Scholar award! 


Landau lab in collaboration with the Kung lab (MSKCC) receives funding from Alex's Lemonade Stand to study cancer evolution of pediatric malignancies with single-cell multi-omics


Dan Landau receives the 2019, Weill Cornell Department of Medicine Young Investigators Award 


Danny Luan receives the 2019 ASH HONORS award 


Asaf Zviran receives the 2018 NYGC Innovation Award for his liquid biopsy work


Nathan Omans Selected as a NYSTEM Stem Cell Biology Scholar


Dan Landau receives the 2018 SU2C Phillip A. Sharp Innovation in Collaboration Award together with Raul Rabadan (CU) 


Dan Landau receives the 2017 American Society of Hematology Joanne Levy, MD, Memorial Award for Outstanding Achievement 


Franco Izzo awarded the American Society of Hematology Outstanding Achievement Abstract Award for submitting the top-scoring abstract of the 2017 annual meeting


Dan Landau selected for HemOnc Today’s Next Gen Innovators 


Columbia University Physical Sciences in Oncology Center pilot grant awarded in collaboration with the Rabadan lab (CU) for novel multi-omics single cell technology development


The Landau Lab receives a 948K$ award from the STARR Cancer Consortium together with the Meissner Lab at the Broad Institute


This award will fund the development of novel epigenetic single-cell and editing technology

The Landau lab receives prestigious Broad Next 10 Catalytic Steps funding


The Broad Institute will provide 500,000$ in funding over the next year to develop "Modeling Cancer Diversity and Evolution for Precision Combination Cancer Therapeutics". This ambitious project will be carried out jointly with Cory Johannessen at the Broad Institute, to identify novel ways to overcome lung cancer evolution and resistance to therapy. 

The Landau Lab receives an Innovative Research Grant from the Stand Up To Cancer foundation.


This award will fund a project titled: "Algorithmically-driven Quantitative Combination Cancer Therapy Engineering."


Dan Landau receives the 2016 Kimmel Scholar Award by the Sydney Kimmel Foundation.


The Kimmel Scholar award will fund a project titled: "Knowledge infrastructure for data-driven combination leukemia therapy engineering." 


Our study "Clonal evolution in patients with chronic lymphocytic leukemia developing resistance to BTK inhibition" was accepted for publication in Nature Communications


Dan Landau receives the 2016 Young Physician-Scientist Award by the American Society of Clinical Investigation


To be presented in April at the AAP-ASPA-ASCI joint annual meeting in Chicago. 



The Landau Lab receives the Leukemia Lymphoma Society Translational Research Program Award. 


This award will fund the development of dynamic therapeutic optimization based on liquid biopsy technology

The Landau Lab receives a 200K$ award from the Meyer Cancer Center Liquid Biopsy Initiative


This award will fund the development of new liquid biopsy technology for early cancer detection

Quantitative Clonal Dynamics Define Mechanisms of CLL Evolution in Response to Combination Chemotherapy – selected for Best of ASH


Dense temporal sampling of leukemia samples from patients treated with chemoimmunotherapy enabled the study of evolutionary kinetics directly in patients. These data describe innovative methodologies to measure clone-specific growth rates with differing therapeutic contexts. The project lays the foundations for algorithmycally-driven therapy based on real-time monitoring of clonal growth. The results were presented at the annual meeting of the American Society of Hematology (ASH) and selected for the Best of ASH presentation.  

bottom of page